How effective is the COMIRNATY BNT162b2 vaccine against the SARS-CoV-2 Lambda variant?

how effective is the comirnaty bnt162b2 vaccine against the sars cov 2 lambda variant

Sumary of How effective is the COMIRNATY BNT162b2 vaccine against the SARS-CoV-2 Lambda variant?:

  • Coronavirus disease 2019 (COVID-19) has caused over five million deaths and spread to nearly every country in the world.
  • These variants of concern (VOCs) show several worrying traits – they show increased transmission compared to wild-type severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and can evade both natural and vaccine-induced immunity.
  • The Lambda variant, like many other variants, is characterized by mutations in the spike proteins, including 75V, T76I, Δ246–252, L452Q, F490S, D614G, and T859N.
  • The spike protein is key to the pathogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
  • It is a trimeric surface protein formed of two subunits that must be cleaved by a host protein, S1 and S2. Related StoriesS1 contains a receptor-binding domain (RBD) that can bind to angiotensin-converting enzyme 2 (ACE2) among other receptors in order to permit viral cell entry.
  • When the proteins are facing down, they are less likely to induce an immune response – this is the evolutionary tactic the wild-type SARS-CoV-2 attempted.
  • However, when they face up, the protein shows significantly improved ACE2 binding and is far more infective – often seen in variants.
  • The neutralizing titers against the Lambda variant were compared against wild-type (WT), the Alpha variant and the Delta variant.

Want to know more click here go to source.

From -


Site Language

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.